March 18, 2025

Anesthesia and Respiratory Devices Market Size to Cross USD 90.18 Bn by 2034

The anesthesia and respiratory devices market size is projected to cross around USD 90.18 billion by 2034 from USD 47.41 billion in 2024, with a CAGR of 6.64%.

Anesthesia and Respiratory Devices Market Size 2025 to 2034

Get Sample Copy of Report@ https://www.precedenceresearch.com/sample/1098

Key Points

  • North America accounted for the highest revenue share of 26% in 2024.
  • Asia-Pacific is expected to witness the most rapid growth during the forecast period.
  • Among product categories, the respiratory devices segment emerged as the dominant segment in 2024.

Market Drivers

The rising need for efficient anesthesia and respiratory support systems due to the increasing number of surgeries worldwide is a significant driver of market growth. Lifestyle changes, urbanization, and exposure to environmental pollutants have led to a higher incidence of respiratory diseases, further increasing demand for respiratory therapy devices.

Advancements in sensor-based and AI-driven medical devices are also improving diagnostic capabilities and enhancing patient care. The increased focus on personalized medicine and patient-specific respiratory therapies is further propelling market expansion.

Opportunities

The development of innovative, cost-effective anesthesia and respiratory devices tailored for emerging markets offers substantial growth potential. The increasing adoption of cloud-based and AI-integrated respiratory monitoring systems enables healthcare providers to track patient conditions remotely, driving demand for smart devices.

Additionally, the rise in government funding and public-private partnerships aimed at strengthening respiratory care infrastructure in underserved regions presents an opportunity for market players.

Challenges

The complex regulatory approval process for new anesthesia and respiratory devices slows down innovation and market entry. Additionally, a lack of standardization in respiratory care protocols across different regions creates challenges for global manufacturers.

High maintenance costs associated with advanced respiratory equipment can be a barrier for hospitals with budget constraints. Moreover, cybersecurity threats in connected medical devices pose risks related to patient data security and device functionality.

Regional Insights

North America leads the global market, supported by strong R&D initiatives, favorable reimbursement policies, and high adoption rates of advanced medical technologies. The Asia-Pacific region is poised for significant expansion, fueled by rising healthcare investments, increasing patient awareness, and improving hospital infrastructure.

Europe maintains steady growth due to strict quality standards and technological innovations in respiratory and anesthesia devices. Meanwhile, emerging markets in Latin America, the Middle East, and Africa are experiencing gradual adoption, driven by international healthcare collaborations and infrastructure improvements.

Anesthesia and Respiratory Devices Market Companies

  • Masimo Corporation
  • Medtronic
  • AirSep Corporation
  • Smiths Medical
  • GE Healthcare
  • Philips Healthcare
  • Braun Medical Inc.
  • Drägerwerk AG & Co
  • KGaA
  • Getinge AB
  • Teleflex Inc

Recent Developments

  • In October 2023, AirLife, a leading manufacturer and distributor of medical devices for anesthesia and respiratory care in North American, announced the completion of its respiratory business: BALLARD, MICROCUFF, and endOclear product lines, from Avanos Medical, Inc. The acquisition enables AirLife to enhance its product portfolio of anesthesia and respiratory care.
  • In June 2023, Avanos Medical, Inc. agreed to sell its Regenerative Medicine (RH) business to SunMed Group Holdings, LLC (SunMed), a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care.
  • In March 2023, SunMed, a leading North American manufacturer and distributor of medical devices for anesthesia and respiratory care, announced a definitive agreement with Vyaire Medical, under which SunMed will acquire Vyaire’s business, which manufactures and sells respiratory and anesthesia supplies for airway management and surgical treatment.

Segments Covered in the Report

By Product

  • Anesthesia Devices
    • Machines
      • Workstations
      • Monitors
      • Ventilators
      • Delivery machines
        • Standalone
        • Portable
      • Disposables
        • Disposable Accessories
        • Disposable Masks
  • Respiratory Devices
    • Disposables
      • Disposable Oxygen Masks
      • Resuscitators
      • Tracheostomy Tubes
      • Oxygen Cannula
    • Equipment
      • Reusable Resuscitators
      • Ventilators
        • Adult Ventilators
        • Neonatal ventilators
      • Positive Airway Pressure
        • Bi-level positive airway pressure devices
        • Continuous positive airway pressure devices
      • Nebulizers
        • Pneumatic nebulizers
        • Mesh nebulizers
        • Ultrasonic nebulizers
      • Inhalers
        • Dry powdered inhalers
        • Metered-dose inhaler
      • Humidifiers
        • Heat exchangers
        • Pass over humidifiers
        • Heat humidifiers
        • Heated wire breathing circuits
      • Oxygen Concentrators
        • Portable oxygen concentrators
        • Fixed oxygen concentrators
      • Measurement Devices
        • Spirometers
        • Pulse Oximeters
        • Capnography
        • Peak Flow Meters

 By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/